ARCHIVED 1. List of Drugs for Exceptional Importation and Sale [2020-05-19]
Notice to Reader:
This is an archived list. Please refer to the most current version of this list.
Drugs included on this list are called “designated drugs” and are eligible for the exceptional importation and sale provisions provided for in the Interim Order. The list, which will be updated as required, is incorporated by reference in the IO and is maintained by Health Canada.
Supersedes: 2020-05-12
Date issued: 2020-05-15
Access archived versions of this list.
Drug or Class of Drug; Brand Name, Medicinal Ingredient(s) | Dosage Form, Strength, Route of Administration | Country of Origin and Identifying Code | Name of Importer | Batch Number | Date |
---|---|---|---|---|---|
Propofol; Fresenius Propoven, propofol | Emulsion for injection or infusion, 100mL vial - 20mg/mL (2%), Intravenous use | Austria and Sweden, Inner vial label: M080395 Outer box label: M080396 Package leaflet: M080510 |
Fresenius Kabi Canada Ltd. | N/A | April 16, 2020 |
Midazolam; Midazolam Injection, USP 2 mg / 2 mL (1 mg / mL), Midazolam |
Solution for injection, 1 mg/1 mL, Intravenous and intermuscular use |
USA, ANDA 203460 | Fresenius Kabi Canada Ltd. | N/A | April 17, 2020 |
Ceftriaxone; Ceftriaxone for Injection USP 1g, Ceftriaxone |
Powder, 1g, Intramuscular or intravenous use |
United States, National Drug Code (NDC): 00409-7332-01 |
Pfizer Canada ULC | N/A | April 17, 2020 |
Ketamine; Ketamine Hydrochloride Injection USP 500mg/5mL, Ketamine Hydrochloride |
Solution - concentrate, 100mg/mL, Intramuscular or intravenous use |
United States, National Drug Code (NDC): 00409-2051-05 |
Pfizer Canada ULC | N/A | April 17, 2020 |
Norepinephrine; Levophed Injection USP 4mg/4mL, Norepinephrine Bitartrate |
Solution - concentrate, 1mg/mL, Intravenous infusion following dilution |
United States, National Drug Code (NDC): 00409-3375-04 |
Pfizer Canada ULC | N/A | April 17, 2020 |
Midazolam; Midazolam Injection USP 2mg/2mL, Midazolam |
Solution, 1mg/mL, Intramuscular or intravenous use |
United States, National Drug Code (NDC): 00409-2305-17 |
Pfizer Canada ULC | N/A | April 17, 2020 |
Midazolam; Midazolam Injection USP 5mg/5mL, Midazolam |
Solution, 1mg/mL, Intramuscular or intravenous use |
United States, National Drug Code (NDC): 00409-2305-05 |
Pfizer Canada ULC | N/A | April 17, 2020 |
Midazolam; Midazolam Injection USP 10mg/10mL, Midazolam |
Solution, 1mg/mL, Intramuscular or intravenous use |
United States, National Drug Code (NDC): 0409-2587-05 |
Pfizer Canada ULC | N/A | April 17, 2020 |
Pancuronium; Pancuronium Bromide Injection USP 10mg/10mL, Pancuronium Bromide |
Solution, 1mg/mL, Intravenous use only |
United States, National Drug Code (NDC): 00409-4646-01 |
Pfizer Canada ULC | N/A | April 17, 2020 |
Dexmedetomidine; Precedex injection 200mcg/2mL, Dexmedetomidine Hydrochloride |
Solution - concentrate, 100mcg/mL, Intravenous use |
United States, National Drug Code (NDC): 00409-1638-02 |
Pfizer Canada ULC | N/A | April 17, 2020 |
Dexmedetomidine; Precedex injection 400mcg/100mL, Dexmedetomidine Hydrochloride |
Solution, 4mcg/mL, Intravenous use |
United States, National Drug Code (NDC): 00409-1660-10 |
Pfizer Canada ULC | N/A | April 17, 2020 |
Succinylcholine Chloride; Quelicin Injection USP 200mg/10mL, Succinylcholine Chloride |
Solution, 20mg/mL, Intramuscular or intravenous use |
United States, National Drug Code (NDC): 00409-6629-02 |
Pfizer Canada ULC | N/A | April 17, 2020 |
Rocuronium; Rocuronium Bromide injection 100mg/10mL, Rocuronium Bromide |
Solution, 10mg/mL, Intravenous use only |
United States, National Drug Code (NDC): 00409-9558-10 |
Pfizer Canada ULC | N/A | April 17, 2020 |
Vecuronium; Vecuronium Bromide for Injection 10mg, Vecuronium Bromide |
Powder for solution, Intravenous use only |
United States, National Drug Code (NDC): 00409-1632-01 |
Pfizer Canada ULC | N/A | April 17, 2020 |
Rocuronium Bromide; Rocuronium Bromide Injection, Rocuronium Bromide |
Solution (sterile), 50mg/5mL (10mg/mL), Intravenous use |
United States, National Drug Code (NDC): 70860-651-05; 70860-651-41, ANDA: 205656 |
SteriMax Inc. | N/A | May 1, 2020 |
Salbutamol; Salbutamol Aldo-Union, Salbutamol sulfate |
Metered-Dose Aerosol, 100mcg per actuation, Inhalation |
Spain, National Health Care Reimbursement Number (NHRN): 797183.2 TLDO; M.A. No. 65.850 |
JAMP Pharma Corporation | N/A | May 7, 2020 |
Azithromycin; Azithromycin for Injection USP, Azithromycin dihydrate |
Powder for solution, 500mg/vial, Intravenous use |
Canada, DIN: 02239952 |
SteriMax Inc. | 200670110 | May 7, 2020 |
Fentanyl; Fentanyl Kalceks, Fentanyl Citrate |
Liquid solution for injection, 50mcg/ml - 10ml ampoules, Intramuscular or intravenous use |
Malta, MA1207/00202 |
Innomar Strategies Inc. on behalf of JAMP Pharma Corporation | N/A | May 7, 2020 |
Fentanyl; Fentanyl Citrate - Kalceks, Fentanyl Citrate |
Liquid solution for injection, 50mcg/ml - 2ml ampoules, Intramuscular or intravenous use |
Latvia, 14-0232 |
Innomar Strategies Inc. on behalf of JAMP Pharma Corporation | N/A | May 7, 2020 |
Morphine; Morphine Sulfate, Morphine Sulfate Pentahydrate |
Solution, 2mg/mL, Intramuscular, intravenous, and subcutaneous use |
Australia, AUST R 308716 |
Innomar Strategies Inc. on behalf of JAMP Pharma Corporation | N/A | May 7, 2020 |
Morphine; Morphine Sulfate, Morphine Sulfate Pentahydrate |
Solution, 10mg/mL, Intramuscular, intravenous, and subcutaneous use |
Australia, AUST R 308718 |
Innomar Strategies Inc. on behalf of JAMP Pharma Corporation | N/A | May 7, 2020 |
Morphine; Morphine Sulfate, Morphine Sulfate Pentahydrate |
Solution, 15mg/mL, Intramuscular, intravenous, and subcutaneous use |
Australia, AUST R 308715 |
Innomar Strategies Inc. on behalf of JAMP Pharma Corporation | N/A | May 7, 2020 |
Morphine; Morphine Sulfate Injection USP, Morphine Sulfate |
Solution, 5mg/mL, Intramuscular, intravenous, and subcutaneous use |
United States, National Drug Code (NDC): 76045-006-10 |
Fresenius Kabi Canada Ltd. | N/A | May 7, 2020 |
Morphine; Morphine Sulfate Injection USP, Morphine Sulfate |
Solution, 4mg/mL Intramuscular, intravenous, and subcutaneous use |
United States, National Drug Code (NDC): 76045-005-10 |
Fresenius Kabi Canada Ltd. | N/A | May 7, 2020 |
Morphine; Morphine Sulfate Injection USP, Morphine Sulfate |
Solution, 2mg/mL, Intramuscular, intravenous, and subcutaneous use |
United States, National Drug Code (NDC): 76045-004-10 |
Fresenius Kabi Canada Ltd. | N/A | May 7, 2020 |
Norepinephrine; Norepinephrine Bitartrate Injection, USP 4mg/4mL (1mg/mL), Norepinephrine Bitartate |
Injection, 1mg/mL, Intravenous use |
United States, National Drug Code (NDC): 36000-162-10 Product Code: AIN00610 |
Baxter Corporation | N/A | May 8, 2020 |
Rocuronium; Rocuronium Bromide Injection, Rocuronium Bromide |
Solution for injection (50mg/5mL), 10mg/mL, Intravenous use |
United States, National Drug Code (NDC): 70860-651-05; 70860-651-41 |
Laboratoire Riva Inc. | N/A | May 8, 2020 |
Hydromorphone; Hydromorphone Kalceks, Hydromorphone hydrochloride |
Solution, 2mg/mL, Intramuscular, intravenous, or subcutaneous use |
Germany, M.A No. (Zulassungnummer): 2201455.00.00 |
Innomar Strategies Inc. on behalf of JAMP Pharma Corporation | N/A | May 11, 2020 |
Hydromorphone; Hydromorphone Kalceks, Hydromorphone hydrochloride |
Solution, 10mg/mL, Intramuscular, intravenous, or subcutaneous use |
Germany, M.A No. (Zulassungnummer): 2201456.00.00 |
Innomar Strategies Inc. on behalf of JAMP Pharma Corporation | N/A | May 11, 2020 |
Hydromorphone; Hydromorphone Kalceks, Hydromorphone hydrochloride |
Solution, 20mg/mL, Intramuscular, intravenous, or subcutaneous use |
Germany, M.A No. (Zulassungnummer): 2201457.00.00 |
Innomar Strategies Inc. on behalf of JAMP Pharma Corporation | N/A | May 11, 2020 |
Hydromorphone; Hydromorphone Kalceks, Hydromorphone hydrochloride |
Solution, 50mg/mL, Intramuscular, intravenous, or subcutaneous use |
Germany, M.A No. (Zulassungnummer): 2201458.00.00 |
Innomar Strategies Inc. on behalf of JAMP Pharma Corporation | N/A | May 11, 2020 |
Meropenem; Meropenem 1000 mg Powder for Solution for Injection or Infusion, Meropenem trihydrate |
Powder for solution, 1000mg, Intravenous use |
Ukraine, Ukraine Registration No. UA/17558/01/01, Manufacturing License No. G/28/1581 |
Strides Pharma Canada Inc. | N/A | May 12, 2020 |
Timolol; Timo-Stulln, Timolol maleate |
Ophthalmic solution, 0.5%, Ophthalmic Use |
Germany, 06879051 |
Pharma Stulln Inc. |
N/A | May 15, 2020 |
Salbutamol; Salbuhaler, Salbutamol sulfate |
Metered-Dose Aerosol, 100 mcg per actuation, Inhalation |
Philippines, DRP-3645 |
Sandoz Canada Inc. |
N/A | May 15, 2020 |
Page details
- Date modified: